Gentiva Health (GTIV) Sees FY12 Revs Below Views
Tweet
Share
E-mailGet Alerts GTIV Hot Sheet
Price: $19.19 --0%
Financial Fact:
Net income attributable to Gentiva shareholders: 0.21
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net income attributable to Gentiva shareholders: 0.21
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Gentiva Health Services, Inc. (Nasdaq: GTIV) announced today its 2012 financial outlook for net revenues and adjusted earnings before interest, taxes, depreciation and amortization attributable to continuing operations (Adjusted EBITDA).
For 2012, Gentiva expects full-year net revenues to be in the range of $1.70 billion to $1.76 billion and Adjusted EBITDA to be $170 million to $190 million. The Street sees revs of $1.77 billion.
Adjusted EBITDA excludes charges related to restructuring, acquisition, integration activities, the cost of legal settlements, goodwill, intangible asset and other long-lived asset impairment and dividend income.
For 2012, Gentiva expects full-year net revenues to be in the range of $1.70 billion to $1.76 billion and Adjusted EBITDA to be $170 million to $190 million. The Street sees revs of $1.77 billion.
Adjusted EBITDA excludes charges related to restructuring, acquisition, integration activities, the cost of legal settlements, goodwill, intangible asset and other long-lived asset impairment and dividend income.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
- UBS says bull market has further to run
Create E-mail Alert Related Categories
Guidance, Hot GuidanceRelated Entities
Dividend, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
